Why the study?
Does surgical debridement cure medically resistant Serratia endocarditis on the tricuspid valve?
Does surgical debridement cure medically resistant Serratia endocarditis on the tricuspid valve?
Surgical debridement may be a reasonable and effective procedure for medically resistant bacterial endocarditis.
Answers are grounded in this paper and cite their sources.
May support debridement in refractory tricuspid cases; leaves open need for prospective confirmation before practice change.
Endocarditis caused bySerratiararely responds well to antibiotics, and is usually fatal. Such infection occurred on the tricuspid valve in a patient with a history of drug abuse. After a prolonged course of antimicrobial therapy, the patient underwent exploratory cardiac surgery without cardiac failure. Surgical debridement of the tricuspid valve effected an apparent cure. Cardiac surgery during active bacterial endocarditis has proved to be a reasonable procedure. Medically resistant infection should be added to the traditional indications for cardiac surgery.
No takes yet. Share an insight, caveat, or question.
RAYMOND H. ALEXANDER (1969) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: